member of the Committee on the Toxicological Effects of Methyl Mercury and chair of the Committee on Toxicants and Pathogens in Biosolids Applied to Land. In 2003, he was designated a lifetime national associate of the National Academies
Mark Cullen is professor of medicine and public health at Yale University School of Medicine. His research interests are in occupational and environmental medicine, including isocyanate exposure in automobile-shop workers, lung cancer in people exposed to asbestos, and lead toxicity in workers. He has published several textbooks, including Clinical Occupational Medicine and Textbook of Clinical Occupational and Environmental Medicine. Dr. Cullen received his MD from Yale University and did his residency in internal medicine. He is a member of the DuPont Epidemiology Review Board, a member of the MacArthur Foundation Network on Socioeconomic Status and Health, and a corporate medical director for the Aluminum Company of America. Dr. Cullen is a member of the Institute of Medicine and served as a member of its Board on Health Sciences.
George Eadon is director of the Division of Environmental Disease Prevention of the New York State Department of Health and associate professor in the Department of Environmental Health Sciences at the State University of New York, Albany. He is actively engaged in a number of biomonitoring studies being conducted by the state of New York. Dr. Eadon has served as assistant and associate professor of chemistry and later as chairman of the Department of Environmental Health Science and Toxicology at the State University of New York, Albany. Dr. Eadon received his PhD in chemistry from Stanford University. He serves on the advisory board of New York’s Environmental Public Health Tracking Grant.
Peter Farmer is an honorary professor in the Department of Biochemistry and Cancer Studies and Molecular Medicine and a joint director of the Cancer Biomarkers and Prevention Group at the University of Leicester, UK. His research group studies the molecular action of carcinogenic and other toxic chemicals and develops biomarkers of exposure and effects. The group is involved in several international collaborations aimed at developing methods for monitoring human exposure to environmental and occupational genotoxic chemicals. One of the major focuses of Dr. Farmer’s research is the in vivo interaction (adduct formation) of environmental chemicals, or their active metabolites, with protein and DNA. He received his DPhil in chemistry from Oxford University. He is the chairman of the Committee on Mutagenicity of Chemicals in Food, Consumer Products, and the Environment of the UK Department of Health. He is also a member of the Health Effects Institute Research Committee.